Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
Metropolis Healthcare IPO is a book build issue of ₹1,204.29 crores. The issue is entirely an offer for sale of 1.37 crore shares of ₹1,204.29 crore.
Metropolis Healthcare IPO bidding started from Apr 3, 2019 and ended on Apr 5, 2019. The allotment for Metropolis Healthcare IPO was finalized on Apr 10, 2019. The shares got listed on BSE, NSE on Apr 15, 2019.
Metropolis Healthcare IPO price band is set at ₹880.00 per share . The lot size for an application is 17. The minimum amount of investment required by an retail is ₹14,909 (17 shares). The lot size investment for sNII is 14 lots (238 shares), amounting to ₹2,09,440, and for bNII, it is 67 lots (1,139 shares), amounting to ₹10,02,320.
The issue includes a reservation of up to 3,00,000 shares for employees offered at a discount of ₹0.00 to the issue price.
Credit Suisse Securities (India) Pvt.Ltd. is the book running lead manager and MUFG Intime India Pvt.Ltd. is the registrar of the issue.
Refer to Metropolis Healthcare IPO RHP for detailed Information.
| IPO Date | April 3, 2019 to April 5, 2019 |
| Listing Date | April 15, 2019 |
| Face Value | ₹2 per share |
| Issue Price Band | ₹877 to ₹880 per share |
| Issue Price Final | ₹880 per share |
| Lot Size | 17 Shares |
| Sale Type | Offer For Sale |
| Total Issue Size | 1,36,85,095 shares (aggregating up to ₹1,204.29 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Share Holding Pre Issue | 5,01,78,680 shares |
| Share Holding Post Issue | 5,01,78,680 shares |
Metropolis IPO offers total 1,36,85,095 shares. Out of which 1,00,38,822 (73.36%) allocated to QIB, 40,15,529 (29.34%) allocated to QIB, 20,07,764 (14.67%) allocated to NII, 13,38,509 (9.78%) allocated to RII and 60,23,293 (44.01%) allocated to Anchor investors.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| QIB Shares Offered | 1,00,38,822 (73.36%) | NA |
| − Anchor Investor Shares Offered | 60,23,293 (44.01%) | NA |
| − QIB (Ex. Anchor) Shares Offered | 40,15,529 (29.34%) | NA |
| NII (HNI) Shares Offered | 20,07,764 (14.67%) | NA |
| Retail Shares Offered | 13,38,509 (9.78%) | 78,735 |
| Employee Shares Offered | 3,00,000 (2.19%) | NA |
| Total Shares Offered | 1,36,85,095 (100.00%) |
| Application Category | Maximum Bidding Limits | Bidding at Cut-off Price Allowed |
|---|---|---|
| Only RII | Up to Rs 2 Lakhs | Yes |
| Only sNII | Rs 2 Lakhs to Rs 10 Lakhs | No |
| Only bNII | Rs 10 Lakhs to NII Reservation Portion | No |
| Only employee | Yes | |
| Employee + RII/NII |
|
Yes for Employee and RII/NII |
Metropolis Healthcare IPO opens on April 3, 2019, and closes on April 5, 2019.
| IPO Open Date | Wed, Apr 3, 2019 |
| IPO Close Date | Fri, Apr 5, 2019 |
| Tentative Allotment | Wed, Apr 10, 2019 |
| Initiation of Refunds | Thu, Apr 11, 2019 |
| Credit of Shares to Demat | Fri, Apr 12, 2019 |
| Tentative Listing Date | Mon, Apr 15, 2019 |
| Cut-off time for UPI mandate confirmation | 5 PM on Fri, Apr 5, 2019 |
Investors can bid for a minimum of 17 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 17 | ₹14,960 |
| Retail (Max) | 13 | 221 | ₹1,94,480 |
| S-HNI (Min) | 14 | 238 | ₹2,09,440 |
| S-HNI (Max) | 66 | 1,122 | ₹9,87,360 |
| B-HNI (Min) | 67 | 1,139 | ₹10,02,320 |
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
Incorporated in 1980, Mumbai based Metropolis Healthcare Limited is a chain of diagnostic companies. It has 106 clinical laboratories 1130 collection centres in seven countries. In India, it has laboratories across 18 states and 173 cities for monitoring of disease, early detection, and diagnostic screening.
The company also provides analytical and support services for the clinical research projects to some clinical research organizations. In the last financial year (2018), approximately 7.7 million patients visited the lab and around 16.0 million tests conducted in the clinics.
Metropolis offers 3,480 clinical laboratory tests and 524 profiles which combines a variety of tests for the specific disease. To provide better services, it has implemented a 'hub and spoke' model. Outside India, the company has a presence in Ghana, Zambia, Kenya, Sri Lanka and Mauritius for laboratory operations and in UAE, Nepal, Nigeria, and Oman for 3rd party services.
It has been recognized by Biotrains for "excellence in customer service and delivery" and FICCI for "service excellence (diagnostic center)" and LH Insights for "best in health and fitness" in 2018.
The competitive strengths of the company are:
1. Well positioned for expected industry growth
2. Widespread operational network
3. Comprehensive test menu
4. Focus on quality and customer service
5. Robust information technology structure
| Particulars | For the year/period ended (in Rs. 10 Lakhs) | |||
|---|---|---|---|---|
| 31-Dec-18 | 31-Mar-18 | 31-Mar-17 | 31-Mar-16 | |
| Total Assets | 5,838.75 | 5,303.40 | 5,151.59 | 3,959.16 |
| Total Revenue | 5,593.06 | 6,435.67 | 5,447.24 | 4,754.69 |
| Profit After Tax | 887.71 | 1,097.47 | 1,072.57 | 819.55 |
[Dilip Davda] Although the sector is fragmented and highly unorganized, MHL has created a niche place amongst organized players with many firsts to its credit. Though the issue appears fully priced, asset light and debt-free status make this offer lucrative. Investors may consider an investment for the long term. Read detail review...
| Listing Date | April 15, 2019 |
| BSE Script Code | 542650 |
| NSE Symbol | METROPOLIS |
| ISIN | INE112L01020 |
| Final Issue Price | ₹880 per share |
| BSE Listing Group | B |
Metropolis Healthcare Ltd.
250 D Udyog Bhavan,
Hind Cycle Marg, Worli
Mumbai 400 030, Maharashtra
Mumbai, Maharashtra
Phone: (91 22) 6258 2810
Email: investor.relations@metropolisindia.com
Website: https://www.metropolisindia.com/
MUFG Intime India Pvt.Ltd.
Phone: +91-22-4918 6270
Email: metropolis.ipo@linkintime.co.in
Website: https://linkintime.co.in/Initial_Offer/public-issues.html
Metropolis Healthcare IPO is a main-board IPO of 1,36,85,095 equity shares of the face value of ₹2 aggregating up to ₹1,204.29 Crores. The issue is priced at ₹880 per share. The minimum order quantity is 17.
The IPO opens on April 3, 2019, and closes on April 5, 2019.
MUFG Intime India Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in Metropolis Healthcare IPO using UPI as a payment gateway. Zerodha customers can apply in Metropolis Healthcare IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Metropolis Healthcare IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Metropolis Healthcare IPO opens on April 3, 2019 and closes on April 5, 2019.
Metropolis Healthcare IPO lot size is 17, and the minimum amount required for application is ₹14,960.
You can apply in Metropolis Healthcare IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Metropolis Healthcare IPO will be done on Wednesday, April 10, 2019, and the allotted shares will be credited to your demat account by Friday, April 12, 2019. Check the Metropolis Healthcare IPO allotment status.
The Metropolis Healthcare IPO listing date is on Monday, April 15, 2019.
Useful Articles
RHP